Sort
25,944 grants matching “neurodegeneration”
Efficacy of GluR5 Antogonists Against Soman-Induced Seizures and Neuropathology
$533,799Maria F Braga · Henry M. Jackson Fdn For The Adv Mil/Med · U01 · FY2013 · NS
A Multidisciplinary Analysis of Gelsolin Amyloid Disease
$533,778Scripps Research Institute · R01 · FY2003 · AG
First-in-class peptide therapeutics for mitochondrial disorders: molecular mechanism of action and optimization of design
$533,698Nathan N Alder · University Of Connecticut Storrs · R01 · FY2020 · AG
Targeting conserved diet-responsive transcriptional networks in neurons to slow neurodegeneration in Alzheimer's disease
$533,500Pankaj Kapahi · Buck Institute For Research On Aging · R21 · FY2021 · AG
Administrative Core
$533,462James Bruce Leverenz · Cleveland Clinic Lerner Com-Cwru · P30 · FY2023 · AG
Elucidating the role of Adaptor Protein complex-4 in regulating axonal autophagic and lysosomal pathways
$533,231Swetha Gowrishankar · University Of Illinois At Chicago · R01 · FY2022 · AG
Viral Host Interactions in SIV Cardiac Dysfunction
$533,231Johns Hopkins University · R01 · FY2004 · HL
Exploration of MRI measures of neurodegeneration within individuals over short intervals
$533,173Randy L Buckner · Harvard University · R01 · FY2020 · AG
Mechanisms of motor neuron toxicity in Kennedy disease
$532,999Andrew P Lieberman · University Of Michigan At Ann Arbor · R01 · FY2018 · NS
Synthetic molecules to stimulate expression of the Frataxin (FXN) and ameliorate Friedreich's Ataxia (FRDA)
$532,963Aseem Z Ansari · University Of Wisconsin-Madison · R01 · FY2018 · NS
Connecting Alzheimer's Disease to Traumatic Synaptic Neurodegeneration
$532,957Terrance T Kummer · Washington University · R01 · FY2025 · NS
Brain Oxygen Metabolism and Hemodynamic Impairment in Multiple Sclerosis
$532,921Yulin Ge · New York University School Of Medicine · R01 · FY2014 · NS
Proteostasis dysregulation and the development of Alzheimer's-like neurodegeneration and dementia in Down syndrome
$532,856Domenico Pratico · Temple Univ Of The Commonwealth · R01 · FY2025 · AG
Aging and Alzheimer's Research Training
$532,797G. William Rebeck · Georgetown University · T32 · FY2024 · AG
Mechanisms of Polyglutamine Neurodegeneration
$532,511Henry L Paulson · University Of Michigan At Ann Arbor · R01 · FY2015 · NS
Therapeutic Potential of FGF21 for Alzheimer's Disease
$532,372Matthew Joseph Potthoff · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2025 · AG
Toxicodietary and genetic determinants of susceptibility to neurodegeneration
$532,332Daniel Desire Tshala-Katumbay · Oregon Health & Science University · R01 · FY2020 · ES
Cathepsin B inhibitor Drug Development for Traumatic Brain Injury
$532,178Gregory R Hook · American Life Science Pharmaceuticals · R41 · FY2018 · NS
The FMR1 CGG repeat as functional element and therapeutic target in Fragile X associated disorders
$532,177Peter K Todd · Baylor College Of Medicine · P50 · FY2020 · HD
Gene Expression in Long-term Memory
$532,158Cristina M Alberini · Icahn School Of Medicine At Mount Sinai · R01 · FY2009 · MH
Use of High Density Lipoprotein Proteome in the Prediction of Cognitive Impairment and Alzheimer's Disease: (REGARDS)
$532,144Robert Sidney Rosenson · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · AG
Ameliorating Synaptic and Mitochondrial Dysfunctions of the Respiratory Neuromotor System in Alzheimer's Disease
$532,073Matthew Fogarty · Mayo Clinic Rochester · R56 · FY2023 · HL
Understanding the Cellular Basis of Movement Disorders
$532,040Puneet Opal · Northwestern University At Chicago · R01 · FY2022 · NS
Understanding the Cellular Basis of Movement Disorders
$532,040Puneet Opal · Northwestern University At Chicago · R01 · FY2021 · NS
Understanding the Cellular Basis of Movement Disorders
$532,040Puneet Opal · Northwestern University At Chicago · R01 · FY2019 · NS